asa statement on glp 1 Adipose Tissue Plasticity, Lipoprotein Metabolism, and Cardiovascular Risk: The Emerging Role of the GLP-1 Axis Are Serious Anesthesia Risks of
Description
A second incretin-based therapeutic approach was the development of GLP-1R agonists (GLP-1RAs)
2019 Jan 6;8(1):15
The study examined time to MACE and its components, hospitalizations for angina or heart failure, and revascularization (coronary and peripheral)
[DOI] [PMC free article] [PubMed] [Google Scholar] 57.Ma X., Liu Z., Ilyas I., Little P.J., Kamato D., Sahebka A., Chen Z., Luo S., Zheng X., Weng J., et al
Qualifying for insurance coverage of brand-name medications through type 2 diabetes or cardiovascular indications rather than weight loss alone can also dramatically reduce costs
